The present invention addresses the problem of how to provide an evaluation method, and the like, capable of providing highly reliable information that can serve as a reference for understanding a mild cognitive impairment state. In an embodiment of the present invention, the mild cognitive impairment state of a subject for evaluation is evaluated using at least one value from among the values of the concentration in the blood of the subject for evaluation of α-ABA, Ala, Arg, Asn, Cit, Glu, Gln, Gly, His, Ile, Leu, Lys, Met, Orn, Phe, Pro, Ser, Thr, Trp, Tyr, Val, taurine, 1-MeHis, 3-MeHis, aAAA, aAiBA, ADMA, allyl Cys, bABA, bAiBA, cystathionine, cysteic acid, EtGly, GABA, hArg, hypotaurine, Hypro, KYN, pyrazole-1-Ala, MCSO, MeCys, N6-AcLys, N8-AcSpd, opthalmic acid, PEA, pipecolic acid, Put, Sar, SDMA, Spd, Spm, and thioproline, and test values for Alb, folate, WBC, RBC, Hb, Ht, and PLT.
MILD-COGNITIVE-IMPAIRMENT EVALUATION METHOD, CALCULATION METHOD, EVALUATION DEVICE, CALCULATION DEVICE, EVALUATION PROGRAM, CALCULATION PROGRAM, RECORDING MEDIUM, EVALUATION SYSTEM, AND TERMINAL DEVICE